Gastroentrologist

  • Placeholder

    FATTY LIVER INDEX

    0 out of 5

    Most of the patients with fatty liver are asymptomatic with normal liver function test. Fatty liver index is an algorithm to predict hepatic steatosis in high risk population. The index has shown good accuracy in detecting NAFLD & has been used in several studies.

    • Pre-test Information:

      Overnight fasting is mandatory.

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report same day

  • Placeholder

    NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE

    0 out of 5

    NAFLD fibrosis score is the most studied score which has been extensively validated in a large population of patients with Non Alcoholic Fatty Liver disease (NAFLD) for detecting significant fibrosis.. NAFLD is the most common cause of abnormal liver function tests in primary care. It is associated with obesity, insulin resistance, Diabetes, Dyslipidemia, hypertension and is considered as hepatic manifestation of the Metabolic syndrome. The pivotal issue in managing patients with NAFLD is the diagnosis of steatohepatitis & fibrosis at early stage. Liver biopsy (the Gold standard for diagnosing & assessing fibrosis) is not considered appropriate as first line tool for diagnosing fibrosis in unselected NAFLD patients. This test has high negative predictive value, thus can be used as first line test to rule out patients without advanced fibrosis thereby preventing unnecessary secondary care referrals.

    • Pre-test Information:

      Overnight fasting mandatory. Patient’s age, height & weight are mandatory.

    • Report Delivery:

      Sample Mon through Sat 9 am; Report Same day

  • Placeholder

    PERNICIOUS ANEMIA PANEL

    0 out of 5

    Vitamin B12 deficiency can be caused by many factors & a group of tests is often required to establish the correct diagnosis. Patients with pernicious anemia (PA) particularly require either massive doses of oral vitamin B12 or parenteral replacement therapy as these patients suffer from gastric mucosal atrophy, most likely caused by a destructive autoimmune process.

    • Pre-test Information:

      Overnight fasting is mandatory. Wrap sample in aluminium foil to protect from light.

    • Report Delivery:

      Sample by Mon 9 am; Report Same day

  • Placeholder

    LIVER FIBROSIS PANEL

    0 out of 5

    Non-invasive tests that suggest advanced liver fibrosis include mild elevation of bilirubin, prolongation of prothrombin time, slight decrease in serum albumin and mild thrombocytopenia. Combinations of these blood tests have been used to create models for predicting advanced liver disease. However the confirmatory test is liver biopsy.

    • Pre-test Information:

      Overnight fasting is preferred. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.

    • Report Delivery:

      Sample Daily by 9 am; Report Same Day

  • Placeholder

    HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR

    0 out of 5

    For detection & genotyping of HBV. The mutations analysed include M204I (YMDD to YIDD), L180M, M204V (YMDD to YVDD), A181 T/V and N236T. These mutations are known to cause resistance to Lamivudine, Telbivudine, Entecavir, Adefovir and Tenofovir.

    • Pre-test Information:

      12 hours fasting is recommended

    • Report Delivery:

      Sample Daily by 11 am; Report 7 days

  • Placeholder

    HISTOPATHOLOGY, LIVER BIOPSY PANEL

    0 out of 5
    • Pre-test Information:

      Give brief clinical history

    • Report Delivery:

      Sample Daily by 6 pm; Report 5 days

  • Placeholder

    HEPATITIS B IMMUNITY SCREEN

    0 out of 5

    This test determines the immune status of individuals exposed to HBV.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    GASTRIN STIMULATION BY SECRETIN

    0 out of 5

    Secretin stimulated serum gastrin level is the best laboratory test for diagnosis of Gastrinoma. Minute changes of less than 30% in serum gastrin levels occur in normal subjects or those with duodenal ulcer. Gastrinoma patients show an increase of at least 200 pg/mL or 50% by 5 or 10 minutes.

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

  • Placeholder

    LIVER PANEL 2

    0 out of 5

    This test panel assesses the functional activity of the liver.

    • Pre-test Information:

      Overnight fasting is preferred. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.

    • Report Delivery:

      Daily

  • Placeholder

    UROBILINOGEN, QUALITATIVE, 24 HOUR URINE

    0 out of 5
    • Pre-test Information:

      24 hour urine without preservative, in a dark coloured container. Keep specimen refrigerated during collection and protect from light.

    • Report Delivery:

      Daily

  • Placeholder

    AMYLASE (DIASTASE), URINE

    0 out of 5

    Urinary amylase is useful in differentiating between Macroamylasemia and Pseudocyst of the pancreas. In case of the former, only serum levels are raised. In Pseudocysts, urinary level remains elevated for weeks after an episode of Acute pancreatitis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    FECAL ELASTASE

    0 out of 5

    Pancreatic elastase remains undegraded during intestinal transit,thus reduced concentration in feces reflects exocrine pancreatic insufficiency caused by Chronic Pancreatitis, Diabetes Mellitus, Cholelithiasis, Cystic Fibrosis, Pancreatic Cancer, Celiac disease etc. It may also be used for monitoring patients on treatment for pancreatic insufficiency

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon 9 am; Report Same day.

  • Placeholder

    INTRINSIC FACTOR ANTIBODY

    0 out of 5

    Intrinsic Factor, produced by cells lining the stomach, binds vitamin B12 (cyanocobalamin) to facilitate absorption of the vitamin. This antibody impedes the action of Intrinsic Factor as observed in approximately half of the patients who develop Pernicious anemia.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon 9 am; report Same day

  • Placeholder

    ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY), IgG

    0 out of 5

    Antibodies to Saccharomyces cerevisiae are found in approximately 75% patients with Crohn’s disease, 15% patients with Ulcerative colitis and 5% of healthy population. This assay helps in distinguishing between Ulcerative colitis & Crohn’s disease in patients suspected of inflammatory bowel disease.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    GLIADIN DEAMIDATED ANTIBODY, IgG

    0 out of 5

    Ingestion of Gliadin peptides contained in wheat, rye and barley induce immune mediated inflammation of small intestine in genetically susceptible individuals with Gluten sensitive enteropathy / Celiac disease. This disease is more common in first and second degree relatives of patients with Celiac disease, individuals with Down Syndrome, Turner syndrome, Williams syndrome, Selective IgA deficiency and Autoimmune disorders. Usage of Deamidated molecule increases the specificity and sensitivity of the assay.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    GLIADIN DEAMIDATED ANTIBODY, IgA

    0 out of 5

    Ingestion of Gliadin peptides contained in wheat, rye and barley induce immune mediated inflammation of small intestine in genetically susceptible individuals with Gluten sensitive enteropathy / Celiac disease. This disease is more common in first and second degree relatives of patients with Celiac disease, individuals with Down Syndrome, Turner syndrome, Williams syndrome, Selective IgA deficiency and Autoimmune disorders. Usage of Deamidated molecule increases the specificity and sensitivity of the assay.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    HEPATITIS DELTA ANTIBODY (Anti-HDV), IgM

    0 out of 5

    Hepatitis D occurs in patients infected with HBV. Presence of Hepatitis D antibody and HBsAg indicate a coinfection. Patients with Hepatitis D are more likely to develop fulminant hepatitis and chronic hepatitis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Wed 11 am; Report Same day

  • Placeholder

    ENDOMYSIAL ANTIBODY, IgA, IFA IN DILUTIONS

    0 out of 5

    Circulating IgA endomysial antibodies (EMA) are present in 70 to 80% patients with Celiac disease and Dermatitis herpetiformis. This assay is useful in the evaluation of these diseases. It also monitors adherence to Gluten free diet. The titre generally corelates well with the severity of Gluten sensitive enteropathy.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

  • Placeholder

    PARIETAL CELL ANTIBODY, IFA IN DILUTIONS

    0 out of 5

    Parietal cell antibodies are found in 70– 90% patients with Pernicious anemia, 50% individuals with Gastric atrophy without pernicious anemia and upto 15% of unselected adult population. This assay is useful for evaluating patients suspected of having Pernicious anemia or immune meditated deficiency of vitamin B12 with or without Megaloblastic anemia.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

  • Placeholder

    MITOCHONDRIAL ANTIBODY (AMA), IFA IN DILUTIONS

    0 out of 5

    Mitochondrial antibody is present in approximately > 90% patients with Primary Biliary Cirrhosis. This assay is not useful for indicating the prognosis of the disease or monitoring the course of the disease.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

  • Placeholder

    VASOACTIVE INTESTINAL POLYPEPTIDE; VIP

    0 out of 5

    VIP is a neurotransmitter and its excess can cause secretory diarrhea. VIP- secreting tumors are most commonly found in the tail of the pancreas in adults. VIP-producing Ganglioneuromas or Ganglioneuroblastomas may be found in the adrenal glands in children.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    TRYPSIN

    0 out of 5

    Trypsin (or trypsinogen) is considered a specific indicator of pancreatic damage. Increased values over the determined normal range may indicate inflammatory pancreatic condition.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    RETICULIN IgA ANTIBODY

    0 out of 5

    Anti-Reticulin IgA occurs most frequently in patients with gluten sensitive enteropathy, i.e. Celiac disease and Dermatitis herpetiformis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    AMYLASE ISOENZYMES

    0 out of 5

    Amylase is produced primarily in the pancreas and salivary glands. It is also produced by small intestine, ovaries, placenta, liver and fallopian tubes. Isoenzymes may be used to determine the source of an elevated amylase concentration.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    ALPHA-1-ANTITRYPSIN (AAT) PHENOTYPE

    0 out of 5

    More than 40 phenotypes of AAT exist. The inherited deficiency seen most often as the ZZ, SS & SZ phenotypes is associated with Neonatal hepatitis & Infantile cirrhosis. In adults these phenotypes are associated with chronic lung disease including Emphysema & Chronic bronchitis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    GASTRIN

    0 out of 5

    Gastrin is a peptide hormone produced by mucosal G cells of gastric antrum. Gastrin levels are pathologically increased in Gastrinoma, Gastric outlet obstruction and Hypo / Achlorhydria. This assay is used to investigate patients with Achlorhydria / Pernicious anemia and Zollinger- Ellison syndrome. The assay is extremely useful in the diagnosis of Gastrinoma.

    • Pre-test Information:

      Patient should strictly avoid drugs like Aldomet (Alpha methyldopa), Labetalol, Isoproterenol, Isoetharine, Alpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Nicotine, Phenacetin, Theophylline, Phenothiazine, Vasodilato(Minoxidil, Nitrates & Hydralazine), Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blocke(long term use), L-dopa, Cimetidine, clofibrate, MAO inhibitors, Propranolol, Penicillin, Reserpine, Thyroxine, vigorous exercise, severe stress and cigarette smoking at least 72 hrs before and during specimen collection.

    • Report Delivery:

      Sample by Mon / Thu 4 pm; Report Same day

  • Placeholder

    CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION

    0 out of 5

    SNP- microarray can identify unbalanced chromosomal abnormalities (loss and/or gain of DNA) in patients with unexplained abnormal phenotypes such as mental retardation, developmental delay, dysmorphic features, congenital anomalies, and autism. SNP-based arrays also identify long contiguous stretches of homozygosity which may suggest an increased likelihood for a recessive condition or uniparental disomy.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report 10 days

  • Placeholder

    BILIRUBIN, FLUID

    0 out of 5
    • Pre-test Information:

      Wrap sample in aluminium foil to protect from light

    • Report Delivery:

      Daily

  • Placeholder

    PROTEIN, TOTAL, BODY FLUIDS

    0 out of 5

    Exudates show high total protein concentrations which may be due to inflammatory, neoplastic or traumatic conditions. Transudates show low total protein concentrations and may be due to heart failure.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    AMYLASE, FLUID

    0 out of 5

    This assay detects increased levels of amylase in fluids like pleural fluid in cases of Acute pancreatitis and Pancreatic pseudocyst. It may also be elvated in cases of Peptic ulcer and Mesenteric vascular occlusion.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE ‘TA’ REPEATS) DETECTION

    0 out of 5

    UGT1A1 gene polymorphism is associated with Gidlbert syndrome, Crigler Nijjar syndrome and with irinotecan toxicity

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Wed / Sat by 11 am; Report 10 days

  • Placeholder

    HEPATITIS G VIRUS RNA DETECTION , PCR

    0 out of 5

    This assay is useful for the detection of Hepatitis G virus in the plasma of the patient.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 11 am; Report 18 days

  • Placeholder

    HEPATITIS D VIRUS DETECTION, PCR

    0 out of 5

    This assay is useful for the detection of Hepatitis D virus in the plasma of the patient.

    • Pre-test Information:

      12 hours fasting is recommended.

    • Report Delivery:

      Sample Daily by 11 am; Report 13 days

  • Placeholder

    HEPATITIS A VIRUS RNA DETECTION, PCR

    0 out of 5

    This assay is useful for the detection of Hepatitis A virus in the plasma of the patient.

    • Pre-test Information:

      12 hours fasting is recommended.

    • Report Delivery:

      Sample Daily by 11 am; Report 10 days

  • Placeholder

    HEPATITIS E VIRUS DETECTION, PCR

    0 out of 5

    Acute infections primarily affect adults, 15 to 40 years of age and are generally mild but the mortality rate is particularly high (10 – 40%) among pregnant women. Chronic HEV infections have been reported in immune suppressed people. This test is useful for the detection of HEV in plasma or serum samples.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample by Mon / Thu11 am; Report Wed / Sat

  • Placeholder

    HLA DNA HIGH RESOLUTION TYPING A, B, C, DR & DQ

    0 out of 5

    A high resolution typing result is defined as a set of alleles that specify and encode the same protein sequence for the peptide binding region of an HLA molecule and that excludes alleles that are not expressed as cell surface proteins. This test is used for HLA typing at a minimum of 4 digits in Bone Marrow Transplants.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 a.m; Report 8 days.

  • Placeholder

    INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING, QUALITATIVE, PCR

    0 out of 5

    IL28B genotype has the strongest predictive value among host factors associated with sustained virologic response. A single nucleotide polymorphism (rs12979860) is strongly associated with a Sustained Virologic Response in HCV genotype 1 infections and to a lesser extent with HCV genotypes 2 & 3.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu / Mon 9 am; Report Sat / Wed

  • Placeholder

    ADENOVIRUS ANTIGEN FOR GASTROENTERITIS. STOOL

    0 out of 5

    Adenovirus is one of the commonest causes of severe gastroenteritis in infants and young children. There are 51 Adenovirus serotypes that have been identified.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 1 pm Report Same day

  • Placeholder

    ENTEROVIRUS ANTIGEN, STOOL

    0 out of 5

    Enteroviruses can cause a wide spectrum of diseases in humans. All Enteroviruses are transmitted by the fecal oral route, but clinical outcomes may go beyond gastroenteritis, as they may infect other organs also.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 1 pm R Same day

  • Placeholder

    ENTEROHEMORRHAGIC E.COLI, VEROTOXIN 1 & 2 ANTIGEN

    0 out of 5

    Entero hemorrhagic E Coli (EHEC) VT 1 & VT 2 infection presents with a wide spectrum of clinical manifestations, including asymptomatic carrier state, non bloody diarrhea , hemorrhagic colitis and hemolytic uremic syndrome.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily by 1 pm R Same day

  • Placeholder

    LISTERIA ANTIGEN, STOOL

    0 out of 5

    Listeria monocytogenes is a food borne pathogen that can cause serious invasive illness in certain well defined high risk groups, including elderly and immunocompromised patients, pregnant women, newborns and infants.

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Daily 1 pm Report Same day

  • Placeholder

    CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE), SCREENING

    0 out of 5

    ESBL screening test is for the detection of Extended Spectrum β-Lactamase-producing organisms. This test provides presumptive identification of ESBL-producing E. coli, Klebsiella, Enterobacter, Serratia and Citrobacter group (KESC), direct from clinical samples or well isolated colonies. This test is useful for epidemiological and hospital infection control purposes.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

  • Placeholder

    HLA – PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS II, QUANTITATIVE

    0 out of 5

    High PRA is associated with delayed graft function, high incidence of acute rejection and short graft survival.

    • Pre-test Information:

      Give brief clinical history. Collect specimen preferably 48 hours after dialysis

    • Report Delivery:

      Sample by Thu; Report Sat

  • Placeholder

    HLA – PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS I, QUANTITATIVE

    0 out of 5

    High PRA is associated with delayed graft function, high incidence of acute rejection and short graft survival.

    • Pre-test Information:

      Give brief clinical history. Collect specimen preferably 48 hours after dialysis

    • Report Delivery:

      Sample by Thu; Report Sat

  • Placeholder

    HLA – CELIAC DISEASE (DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8)

    0 out of 5

    Some DQ2 & DQ3 alleles are associated with higher risk of Celiac disease. This assay is very useful as a negative marker and may be used in first degree relatives of an index case.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 a.m; Report Next day

  • Placeholder

    COPPER, SERUM

    0 out of 5

    Copper is an essential element that is a cofactor of many enzymes. Copper metabolism is disturbed in Wilson’s disease, Menkes disease, Primary Biliary Cirrhosis and Indian childhood cirrhosis. Copper concentrations increase in acute phase reactions. They decrease in nephrosis, malabsorption and malnutrition. Copper levels are also useful to monitor patients specially preterm newborns on nutritional supplementation. Results of copper are often interpreted together with ceruloplasmin.

    • Pre-test Information:

      If gadolinium, iodine or barium containing contrast media has been administered, the specimen should not be collected for 96 hours

    • Report Delivery:

      Sample Daily by 6 pm; Report Next day

  • Placeholder

    COPPER, RANDOM URINE

    0 out of 5

    Copper is an essential element that is a cofactor of many enzymes. Copper metabolism is disturbed in Wilson’s disease, Menkes disease, Primary Biliary Cirrhosis and Indian childhood cirrhosis.Urinary copper concentrations are also used to monitor patients on chelation therapy.

    • Pre-test Information:

      If barium containing contrast media has been administered, the specimen should not be collected for 96 hours

    • Report Delivery:

      Sample Daily by 6 pm; Report Next day

  • Placeholder

    COPPER, 24-HOUR URINE

    0 out of 5

    Copper is an essential element that is a cofactor of many enzymes. Copper metabolism is disturbed in Wilson’s disease, Menkes disease, Primary Biliary Cirrhosis and Indian childhood cirrhosis. Urinary copper concentrations are also used to monitor patients on chelation therapy.

    • Pre-test Information:

      If barium containing contrast media has been administered, the specimen should not be collected for 96 hours

    • Report Delivery:

      Sample Daily by 6 pm; Report Next day

  • Placeholder

    ANTI SOLUBLE LIVER ANTIGEN; SLA

    0 out of 5

    These antibodies are highly specific for Autoimmune hepatitis (AIH) and are present in 30% of cases. In 15% of AIH cases, SLA is the only detectable antibody. This test is specially important in those patients who are negative for all other autoantibodies.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Sat 9 am; Report Same day

  • Placeholder

    SERUM ASCITES ALBUMIN GRADIENT (SAAG)

    0 out of 5

    This assay is considered as the most reliable method to differentiate peritoneal transudate from exudate. Ascitis caused by portal hypertension has gradient greater than 1.1 g/dL (transudate) whereas ascitis due to other causes has a gradient less than 1.1 g/dL (exudate).

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    LACTATE, PLASMA, POST EXERCISE

    0 out of 5

    This assay is useful in the diagnosis of Lactate acidosis which is typically observed in patients with Short bowel syndrome and following Jejunoileal bypass resulting in carbohydrate malasorption. Healthy children presenting with Gastroenteritis may also develop Lactic acidosis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    LACTATE, PLASMA

    0 out of 5

    This assay is useful in the diagnosis of Lactate acidosis which is typically observed in patients with Short bowel syndrome and following Jejunoileal bypass resulting in carbohydrate malasorption. Healthy children presenting with Gastroenteritis may also develop Lactic acidosis.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    CHOLINESTERASE, SERUM

    0 out of 5

    Cholinesterase / Pseudocholinesterase assay is useful for monitoring exposure to Organophosphorus insecticides. It also monitors patients with liver disease particularly those undergoing liver transplantation. However normal values are seen in Chronic hepatitis, mild Cirrhosis & Obstructive jaundice.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    AMMONIA, BLOOD

    0 out of 5

    Ammonia is elevated in liver disease, Reye’s Syndrome, Urea Cycle Enzyme deficiencies and other medical conditions. The correlation with hepatic coma is poor.

    • Pre-test Information:

      No special preparation required. This test is available only at National Reference Lab, Rohini, New Delhi and patient to report to this address only.

    • Report Delivery:

      Daily

  • Placeholder

    HEPATITS E VIRUS (HEV) DETECTION, QUANTITATIVE PCR

    0 out of 5

    HEV is responsible for nearly 50% of Acute viral hepatitis in developing countries of Asia, Africa and Latin America. Acute infections primarily affect adults, 15 to 40 years of age and are generally mild but the mortality rate is particularly high (10 – 40%) among pregnant women. Chronic HEV infections have been reported in immunosuppressed states. Studies in endemic regions indicate high seroprevalence rates ranging from 15 to 60%.

    • Report Delivery:

      Sample by Mon 11 am; Report Sat

  • Placeholder

    Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance

    0 out of 5

    For detection of mutations in the NS5a gene associated with resistance to NS5a inhibitors (examples: daclatasvir, ledipasvir, ombitasvir, elbasvir and velpatasvir). Testing for NS5a resistance-associated variants prior to initiation of treatment with Elbasvir plus Grazoprevir in HCV genotype 1a infected patients is recommended.

    • Pre-test Information:

      na

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • -17%
    Placeholder

    ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY), IgA & IgG PANEL

    0 out of 5

    Antibodies to Saccharomyces cerevisiae are found in approximately 75% patients with Crohn’s disease, 15% patients with Ulcerative colitis and 5% of healthy population. This assay helps in distinguishing between Ulcerative colitis & Crohn’s disease in patients suspected of inflammatory bowel disease.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    3,000.00 2,500.00
  • -5%
    Placeholder

    AUTOIMMUNE HEPATITIS PANEL

    0 out of 5

    This assay is useful for evaluating patients suspected with Chronic Autoimmune Hepatitis (CAH) or Primary Biliary Cirrhosis (PBC). Positive results for ASMA are consistent with the diagnosis of CAH. Presence of LKM antibodies with or without ASMA is consistent with Autoimmune hepatitis Type 2. Presence of AMA is consistent with PBC.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

    • Components:

      4

    6,000.00 5,700.00
  • -25%
    Placeholder

    HEPATITIS C VIRAL COMBO

    0 out of 5

    This test is intended for detection of Genotypes 1, 2, 3, 4, 5 & 6 with subtypes & as an aid in management of HCV infected patients and is not intended for use in the initial diagnosis or confirmation of HCV infection. This test quantifies HCV RNA of free HCV virions in serum / plasma. HCV RNA is a marker of viral replication and persistence is associated with disease progression. This test can be used to monitor response to therapy.

    • Test Type:

      Blood

    • Pre-test Information:

      12 hours fasting is recommended

    • Report Delivery:

      Sample by Tue / Fri 11 am; Report Thu / Mon

    • Components:

      2

    20,000.00 15,000.00
  • -20%
    Placeholder

    PROTEIN, TOTAL, SERUM

    0 out of 5

    Total Protein is useful in evaluating patients for nutritional status, liver disease, protein losing renal and gastrointestinal diseases. High levels are seen in patients with Monoclonal gammopathies, Autoimmune hepatitis and inflamation

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      3

    200.00 160.00
  • -14%
    Placeholder

    GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG

    0 out of 5

    Ingestion of Gliadin peptides contained in wheat, rye and barley induce immune mediated inflammation of small intestine in genetically susceptible individuals with Gluten sensitive enteropathy / Celiac disease. This disease is more common in first and second degree relatives of patients with Celiac disease, individuals with Down Syndrome, Turner syndrome, Williams syndrome, Selective IgA deficiency and Autoimmune disorders. Usage of Deamidated molecule increases the specificity and sensitivity of the assay.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    • Components:

      2

    3,500.00 3,000.00
  • -91%
    Placeholder

    HEPATITIS Be PANEL

    0 out of 5

    HBeAg is found in early phase of HBV infection and correlates with infectivity. It also determines infection status in chronically HBV infected patients. HBe antibody measurement is useful for recognition of resolution of HBV infection with seroconversion of HBeAg to Anti HBe. This usually indicates loss of infectivity but carrier state may persist.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      2

    1,600.00 150.00
  • -3%
    Placeholder

    HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG

    0 out of 5

    Colonization with H.pylori is associated with increased risk of developing gastritis, peptic ulcer disease and gastric malignancies. Antibodies IgG and IgA provide higher sensitivity than either test alone. Antibody titres may be elevated for years in infected individuals. Following treatment, values generally decrease, but may not become undetectable.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    • Components:

      2

    3,200.00 3,100.00
  • -17%
    Placeholder

    BILIRUBIN TOTAL, DIRECT & INDIRECT

    0 out of 5
    • Test Type:

      Blood

    • Pre-test Information:

      Wrap sample in aluminium foil to protect from light

    • Report Delivery:

      Daily

    300.00 250.00
  • -1%
    Placeholder

    LIVER & KIDNEY PANEL

    0 out of 5
    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Daily

    • Components:

      18

    1,500.00 1,480.00
  • -7%
    Placeholder

    HEPATITIS B PROFILE

    0 out of 5

    This test helps to distinguish acute and chronic infection and assesses recovery from or immunity to Hepatitis B.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      6

    4,500.00 4,200.00
  • -2%
    Placeholder

    C. DIFFICILE TOXIN A & B, STOOL

    0 out of 5

    Clostridium difficile is a bacterial pathogen that causes Pseudo-membranous colitis and antibiotic associated diarrhoea. It produces toxins A & B which are enterotoxins. A positive result is considered presumptive evidence of Clostridium diffcile infection.

    • Test Type:

      Stool

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    2,500.00 2,450.00
  • -7%
    Placeholder

    STOOL EXAMINATION, OCCULT BLOOD

    0 out of 5
    • Test Type:

      Stool

    • Pre-test Information:

      Avoid meat products, pain killers, iron tablets, Vitamin C (Ascorbic Acid) and hard tooth brush for 3 days prior to specimen collection.

    • Report Delivery:

      Daily

    150.00 140.00
  • -8%
    Placeholder

    FECAL CALPROTECTIN

    0 out of 5

    Calprotectin is a neutrophilic marker specific for inflammation in the gastrointestinal tract. It is elevated in cases of infections, post-infectious Inflammatory Bowel Syndrome (IBS) & NSAID Enteropathy. Fecal calprotectin is used to differentiate IBD from IBS, to monitor treatment in IBD & to determine patients to be referred for endoscopy and / or colonoscopy.

    • Test Type:

      Stool

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon/ Thu 9 am; Report Same day

    4,000.00 3,680.00
  • -5%
    Placeholder

    TISSUE TRANSGLUTAMINASE TTG-DGP SCREEN

    0 out of 5

    hTTG-DGP Screen is a sensitive and specific screening test for Celiac disease. This test performs simultaneous detection of both IgA & IgG antibodies to a selectively deamidated synthetic peptide (DGP) and human TTG. Even with co-existent IgA deficiency, Celiac disease can be detected.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    2,000.00 1,900.00
  • -5%
    Placeholder

    HELICOBACTER PYLORI ANTIGEN, STOOL

    0 out of 5

    This assay aids in the diagnosis of H.pylori infection and monitor response during and post therapy in patients for treatment effectiveness, relapse or eradication.

    • Pre-test Information:

      Do not use matchbox or absorbent material to collect stool.

    • Report Delivery:

      Sample by Mon 9 am; Report Same day

    2,200.00 2,100.00
  • -7%
    Placeholder

    HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE

    0 out of 5

    This assay is useful to monitor and refine treatment of patients with Chronic Hepatitis B virus infection. It also helps to identify true inactive carriers.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,500.00 1,390.00
  • -6%
    Placeholder

    HEPATITIS E ANTIBODY (Anti-HEV), IgG

    0 out of 5

    HEV causes an acute self limiting infection. Anti HEV IgG appears within a few days of infection and remains positive for several years. This assay is used for the diagnosis of past HEV infection.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon / Wed / Fri 9 am; Report Same day

    1,700.00 1,600.00
  • -9%
    Placeholder

    TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY, IgA

    0 out of 5

    This assay is useful in evaluating patients with Celiac disease including those with compatible symptoms, atypical symptoms and individuals at increased risk like positivity for HLA DQ2 / DQ8. It is also used as a screening test for Dermatitis herpetiformis. The test monitors adherence to gluten free diet.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 am; Report Same day

    1,100.00 1,000.00
  • -3%
    Placeholder

    LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS, IFA

    0 out of 5

    This antibody can be demonstrated in majority of Autoimmune Hepatitis (AIH) cases like Chronic active hepatitis. This assay is useful for evaluating patients with liver disease of unknown etiology and suspected AIH.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

    3,200.00 3,100.00
  • -6%
    Placeholder

    LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA

    0 out of 5

    This antibody can be demonstrated in majority of Autoimmune Hepatitis (AIH) cases like Chronic active hepatitis. This assay is useful for evaluating patients with liver disease of unknown etiology and suspected AIH.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 11 am; Report Same day

    1,700.00 1,600.00
  • -7%
    Placeholder

    HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION

    0 out of 5

    Reactive HBV Neutralization indicates that the patient has circulating Hepatitis B surface antigen. All screen positives must be confirmed by neutralization procedure to rule out false positives due to interfering substances.

    • Pre-test Information:

      Submit previous HbsAg positive report

    • Report Delivery:

      Daily

    700.00 650.00
  • -8%
    Placeholder

    HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL

    0 out of 5

    This assay is useful for diagnosis of recent or past Hepatitis B infection. It helps to determine occult HBV infection in healthy HBV carriers with negative results for HBsAg, Anti HBs, Anti HBc IgM, HBeAg and Anti HBe. This assay is not useful for differentiating between acute, chronic and resolved HBV infection.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,200.00 1,100.00
  • -41%
    Placeholder

    HEPATITIS A ANTIBODY (Anti-HAV), IgG

    0 out of 5

    HAV is a self limiting disease transmitted by the fecal-oral route. Anti HAV IgG levels rise quickly once the virus is cleared and may persist for many years. Presence of Anti HAV IgG indicates immunity against the virus.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    2,000.00 1,190.00
  • -6%
    Placeholder

    SMOOTH MUSCLE ANTIBODY (ASMA), IFA IN DILUTIONS

    0 out of 5

    This assay is useful for evaluating patients with chronic liver disease in whom the diagnosis of Chronic active autoimmune hepatitis is suspected. It may also be positive in Primary biliary cirrhosis, Chronic viral hepatitis and Alcoholic hepatitis. Antibody titres in the range of 80-320 occur commonly in patients with Chronic active hepatitis.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

    3,500.00 3,300.00
  • -6%
    Placeholder

    HELICOBACTER PYLORI, IgG

    0 out of 5

    Colonization with H.pylori is associated with increased risk of developing gastritis, peptic ulcer disease and gastric malignancies. Antibody IgG may not be accompanied by an increase in IgM or IgA antibodies. It may be elevated for years in infected individuals. Following treatment, values generally decrease, but may not become undetectable.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

    1,700.00 1,600.00
  • -6%
    Placeholder

    ENDOMYSIAL ANTIBODY, IgA, IFA

    0 out of 5

    Circulating IgA endomysial antibodies (EMA) are present in 70 to 80% patients with Celiac disease and Dermatitis herpetiformis. This assay is useful in the evaluation of these diseases. It also monitors adherence to Gluten free diet. The titre generally corelates well with the severity of Gluten sensitive enteropathy.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Same day

    1,800.00 1,700.00
  • -3%
    Placeholder

    HEPATITIS C ANTIBODY (Anti-HCV)

    0 out of 5

    HCV is the most common cause of Post transfusion hepatitis. HCV antibodies usually appear in the late convalescent stage >6 months after onset of infection. This assay is the screening test for resolved or chronic HCV.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,500.00 1,450.00
  • -3%
    Placeholder

    LIVER PANEL 1; LFT

    0 out of 5

    This test panel assesses the functional activity of the liver.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    • Components:

      6

    800.00 780.00
  • -11%
    Placeholder

    HEPATITIS Be ANTIBODY; Anti-HBe

    0 out of 5

    This assay is useful for recognition of resolution of HBV infection with seroconversion of HBeAg to Anti HBe. This usually indicates loss of infectivity but carrier state may persist.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    900.00 800.00
  • -10%
    Placeholder

    HEPATITIS Be ANTIGEN; HBeAg

    0 out of 5

    HBeAg is found in early phase of HBV infection and correlates with infectivity. This assay is useful for the diagnosis and monitoring of HBV infectivity. It also determines infection status in chronically HBV infected patients.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,000.00 900.00
  • -8%
    Placeholder

    HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM

    0 out of 5

    This assay is useful for diagnosis of Acute Hepatitis B infection. It identifies Acute HBV infection in the core window period when HBsAg and Anti HBs are negative. It also differentiates between acute and chronic HBV infection in the presence of positive Anti HBc.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    1,200.00 1,100.00
  • -10%
    Placeholder

    HEPATITIS B SURFACE ANTIBODY; ANTI HBs

    0 out of 5

    This assay is useful for identifying previous exposure to HBV and determining adequate immunity from Hepatitis B vaccination.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    800.00 720.00
  • -10%
    Placeholder

    HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN

    0 out of 5

    This assay is useful for the diagnosis of acute, recent and chronic HBV infection. It also determines the chronic Hepatitis B infection status. It is the first serologic marker to appear in the serum at 6 to 16 weeks following exposure to HBV. It usually disappears 1 to 2 months after the onset of symptoms. Persistence >6 months indicates chronic carrier state or chronic HBV infection.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    500.00 450.00
  • -6%
    Placeholder

    HEPATITIS E ANTIBODY (Anti-HEV), IgM

    0 out of 5

    HEV causes an acute self limiting infection. Anti HEV IgM appears within a few days of infection and remains positive upto 6 months. This assay is used for the diagnosis of acute or recent HEV infection.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report Same day

    1,700.00 1,600.00
  • -6%
    Placeholder

    MITOCHONDRIAL ANTIBODY (AMA), IFA

    0 out of 5

    Mitochondrial antibody is present in approximately > 90% patients with Primary Biliary Cirrhosis. This assay is not useful for indicating the prognosis of the disease or monitoring the course of the disease.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Same day

    1,800.00 1,700.00
  • -15%
    Placeholder

    SMOOTH MUSCLE ANTIBODY (ASMA), IFA

    0 out of 5

    This assay is useful for evaluating patients with chronic liver disease in whom the diagnosis of Chronic active autoimmune hepatitis is suspected. It may also be positive in Primary biliary cirrhosis, Chronic viral hepatitis and Alcoholic hepatitis.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 11 am; Report Same day

    2,000.00 1,700.00
  • -4%
    Placeholder

    AMOEBIC SEROLOGY, IgG, SERUM

    0 out of 5

    Entamoeba histolytica is a parasitic protozoan that can infect the digestive tract and occasionally other tissues. Antibody IgG is useful in differentiating Amoebiasis from other causes of liver cysts and pancreatic infection. This is the most sensitive and specific test for Invasive amoebiasis. The test indicates current or previous infection. This test is less sensitive in non-invasive disease.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Wed / / Sat 9 am; Report Same day

    1,400.00 1,350.00
  • -9%
    Placeholder

    HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING

    0 out of 5

    This test is intended for detection and genotyping of HBV. The mutations analysed include M204I (YMDD to YIDD), L180M, M204V (YMDD to YVDD), A181 T/V and N236T. These mutations are known to cause resistance to Lamivudine, Telbivudine, Entecavir, Adefovir and Tenofovir.

    • Pre-test Information:

      The minimum viral load required is 2000 IU/mL

    • Report Delivery:

      Sample Daily by 11 am; Report 7 days

    11,000.00 10,000.00
  • -4%
    Placeholder

    HEPATITIS C VIRAL RNA, GENOTYPE

    0 out of 5

    HCV genotyping assay determines the Genotypes 1,2,3,4,5 & 6 and their subtypes in positive cases. HCV genotype 1 is more difficult to treat than Genotypes 2 & 3 and causes more severe liver disease. This test should not be used for screening of blood or blood products or as a diagnostic test to confirm the presence of HCV infection.

    • Pre-test Information:

      12 hours overnight fasting is recommended.

    • Report Delivery:

      Sample by Tue / Fri 11 am; Report Thu / Mon

    7,000.00 6,700.00
  • -1%
    Placeholder

    HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE, REAL TIME PCR

    0 out of 5

    This test is intended for use as an aid in management of HCV infected patients and is not intended for use in the initial diagnosis or confirmation of HCV infection. This test quantifies HCV RNA of free HCV virions in serum / plasma. HCV RNA is a marker of viral replication and persistence is associated with disease progression. This test can be used to monitor response to therapy.

    • Test Type:

      Blood

    • Pre-test Information:

      12 hours fasting is recommended.

    • Report Delivery:

      Sample by Tue / Fri 11 am; Report Thu / Mon

    9,000.00 8,900.00
  • Placeholder

    HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE, REAL TIME PCR

    0 out of 5

    This test is intended for use as an aid in management of HBV infected patients and is not intended for use in the initial diagnosis or confirmation of HBV infection. It aids in assessing viral response to antiviral treatment as measured by changes in plasma HBV DNA levels.

    • Test Type:

      Blood

    • Pre-test Information:

      12 hours fasting is recommended.

    • Report Delivery:

      Sample by Tue / Thu / Sat 11 am; Report Wed / Fri / Mon

  • -1%
    Placeholder

    HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT, PCR

    0 out of 5

    This test helps to determine the extent of match between donor & recipient. In cases of renal / liver transplants it is preferable to have a higher degree of match as the receipient is likely to generate antibodies for the mismatched antigens which can lead to acute or chronic allograft rejection.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 a.m; Report 2 days

    15,000.00 14,800.00
  • -2%
    Placeholder

    HEPATITIS B VIRUS, PCR, QUALITATIVE; HBV DNA PCR, QUALITATIVE

    0 out of 5

    HBV PCR has immense diagnostic utility in patients who have inconclusive serology results especially in cases of chronic hepatitis B infection and in HBV carriers.

    • Pre-test Information:

      Overnight fasting is recommended.

    • Report Delivery:

      Sample by Tue / Thu / Sat 11 am; Report Wed / Fri / Mon

    4,500.00 4,400.00
  • Placeholder

    HEPATITIS C VIRAL, PCR, QUALITATIVE; HCV RNA, PCR, QUALITATIVE

    0 out of 5

    This test is useful in diagnosing HCV infection prior to seroconversion, distinguishing active from resolved infection and diagnosing chronic hepatitis carriers who are HCV antibody negative.

    • Pre-test Information:

      Overnight fasting is recommended.

    • Report Delivery:

      Sample by Tue / Fri 11 am;Repot Thu / Mon

  • -13%
    Placeholder

    STONE ANALYSIS WITH PICTURE

    0 out of 5

    FTIR spectroscopy is used for stone analysis as the precise wavelength scale improves test accuracy. The routine, easy and rapid measurements give unambiguous information about the stone composition.Therapy for the stone disease is usually based on the analysis of calculi, permitting a proper management of the disease and prevention of its recurrence.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 am; Report Next day

    1,200.00 1,050.00
  • -8%
    Placeholder

    CERULOPLASMIN

    0 out of 5

    Ceruloplasmin is an acute phase protein and a transport protein for copper. It is decreased in Wilson’s disease, an autosomal recessive disorder. Low levels may also occur in Menkes syndrome which is a genetic defect in copper absorption.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample Mon through Sat by 4 pm; Report Same day Sample Sun by 9 am: Report Same day

    1,200.00 1,100.00
  • -10%
    Placeholder

    LIPASE

    0 out of 5

    Lipase is an enzyme produced almost exclusively from pancreatic acinar cells. Pancreatic injury increases serum lipase levels. In Pancreatitis, it rises almost at the same time as amylase (4-8 hrs) but the elevation lasts much longer (7-10 days) as compared to amylase.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    700.00 630.00
  • -7%
    Placeholder

    AMYLASE, SERUM

    0 out of 5

    This is a marker of pancreatic disease being elevated in Acute pancreatitis and acute exacerbation of Chronic pancreatitis. It may also be elevated in cases of drug induced Acute pancreatitis and obstruction of pancreatic duct by stone / carcinoma.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

    450.00 420.00
  • -20%
    Placeholder

    ALKALINE PHOSPHATASE; ALP

    0 out of 5

    Majority of ALP activity is derived from the liver and bone. Concentrations are increased in patients with biliary obstructive disorders, tumors of liver and bone etc.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Daily

    200.00 160.00
  • Placeholder

    BILIRUBIN, DIRECT

    0 out of 5
    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily00000000000000000000000000000000000000000000000000000000

  • Placeholder

    BILIRUBIN, TOTAL

    0 out of 5
    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    SGOT; ASPARTATE AMINOTRANSFERASE (AST)

    0 out of 5

    This enzyme is found in many organs including the liver. Though nonspecific, it is used to detect and monitor liver disease and other medical conditions. This is a more sensitive test in alcoholic liver disease than SGPT.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • -17%
    Diagnostic Centre in Pune

    GGTP (GAMMA GLUTAMYL TRANSPEPTIDASE)

    0 out of 5

    GGTP is a sensitive indicator of biliary tract disease.

    • Test Type:  Blood
    • Pre-test Information:  No special preparation required
    • Report Delivery:  Daily
    300.00 250.00
  • -10%
    Diagnostic Centre in Pune

    SGPT; ALANINE AMINOTRANSFERASE (ALT)

    0 out of 5

    This is an enzyme found mainly in liver tissue and to a lesser extent in heart, kidney and skeletal muscle. Its measurement is clinically useful in the diagnosis of liver and biliary disease.

    • Test Type:  Blood
    • Pre-test Information:  No special preparation required
    • Report Delivery:  Daily
    200.00 180.00
  • -10%
    Diagnostic Centre in Pune

    ENHANCED LIVER FIBROSIS (ELF) PANEL

    0 out of 5

    This assay in conjunction with other laboratory findings and clinical assessment is used as an aid in the diagnosis and assessment of the severity of liver fibrosis in patients with Chronic Liver disease.

    • Pre-test Information:  Overnight fasting is mandatory
    • Report Delivery:  Sample by Mon / Thu 4 pm; Report Next day
    5,000.00 4,500.00
  • -3%
    Diagnostic Centre in Pune

    HEPATITIS C ANTIBODY (Anti-HCV)

    0 out of 5

    HCV is the most common cause of Post-transfusion hepatitis. HCV antibodies usually appear in the late convalescent stage >6 months after onset of infection. This assay is the screening test for resolved or chronic HCV.

    • Test Type:  Blood
    • Pre-test Information:  No special preparation required
    •  Report Delivery:  Daily
    1,500.00 1,450.00